|
If certain symptoms or the results of early detection tests --
the prostate-specific antigen (PSA) blood test and/or digital rectal
exam (DRE) -- suggest that you might have prostate cancer, your doctor
will do a prostate biopsy to find out if the disease is present.
The prostate biopsy
A biopsy is a procedure in which a sample of body tissue is
removed and then looked at under a microscope. A core needle biopsy
is the main method used to diagnose prostate cancer. It is usually done
by a urologist, a surgeon who treats cancers of the genital and urinary
tract, which includes the prostate gland. Using transrectal ultrasound
(described in the section, "Can
prostate cancer be found early?") to "see" the prostate
gland, the doctor quickly inserts a needle through the wall of the
rectum into the prostate gland. When the needle is pulled out it
removes a small cylinder of tissue, usually about 1/2-inch long and
1/16-inch across. This is repeated from 8 to18 times, although most
urologists will take about 12 samples. These are sent to the lab to see
if cancer is present.
Though the procedure sounds painful, it may only cause a very
brief, uncomfortable sensation because it is done with a special
spring-loaded biopsy instrument. The device inserts and removes the
needles in a fraction of a second. Most doctors who do the biopsy will
numb the area first with local anesthetic. You might want to ask your
doctor if he or she plans to do this.
Some doctors will do the biopsy through the perineum, the skin
between the rectum and the scrotum. The doctor will place his or her
finger in your rectum to feel the prostate and then insert the biopsy
needle through a small incision in the skin of the perineum. The doctor
will also use a local anesthetic to numb the area.
The biopsy itself takes about 15 minutes and is usually done
in the doctor's office. You will likely be given antibiotics to take
before the biopsy and for a day or 2 after to reduce the risk of
infection.
For a few days after the procedure, you may feel some soreness
in the area and will likely notice blood in your urine. You may also
have some light bleeding from your rectum. Many men also see some blood
in their semen, which can last for several weeks after the biopsy.
Your biopsy samples will be sent to a pathology lab. There, a pathologist (a
doctor who specializes in diagnosing disease in tissue samples) will
see if there are cancer cells in your biopsy by looking at the samples
under the microscope. If cancer is present, the pathologist will also
assign it a grade
(see below). Getting the results usually takes at least 1 to 3 days,
but it can take longer.
Even with many samples, biopsies can still sometimes miss a
cancer if none of the biopsy needles pass through it. This is known as
a "false negative" result. If your doctor still strongly suspects
prostate cancer (due to a very high PSA level, for example) a repeat
biopsy may be needed to help be sure.
Grading the prostate cancer
Almost all pathologists grade prostate cancers according to
the Gleason system. This system assigns a Gleason grade, using numbers
from 1 to 5 based on how much the cells in the cancerous tissue look
like normal prostate tissue.
- If the cancerous tissue looks much like normal prostate
tissue, a grade of 1 is assigned.
- If the cancer lacks these normal features and its cells
seem to be spread haphazardly through the prostate, it is called a
grade 5 tumor.
- Grades 2 through 4 have features in between these extremes.
Because prostate cancers often have areas with different
grades, a grade is assigned to the 2 areas that make up most of the
cancer. These 2 grades are added together to yield the Gleason score (also
called the Gleason sum) between 2 and 10.
- Cancers with Gleason scores of 2 to 4 are sometimes called
well-differentiated or low-grade.
- Cancers with Gleason scores of 5 to 7 may be called
moderately-differentiated or
intermediate-grade.
- Cancers with Gleason scores of 8 to 10 may be called
poorly-differentiated or high-grade.
The higher your Gleason score, the more likely it is that your
cancer will grow and spread quickly.
Other elements of a biopsy report
The pathologist's report contains the grade of the cancer (if
it is present) but it also often contains other pieces of information
that may give a better idea of the scope of the cancer. These can
include:
- the number of biopsy core samples that contain cancer (for
example, "7 out of 12")
- the percentage of cancer in each of the cores
- whether the cancer is on one side (left or right) of the
prostate or both sides (bilateral)
Suspicious results
Sometimes when the pathologist looks at the prostate cells
under the microscope, they don't look cancerous, but they're not quite
normal, either. These results are often reported as suspicious. They
generally fall into 2 categories -- either prostatic intraepithelial
neoplasia (PIN) or atypical small acinar proliferation (ASAP).
In PIN, there are changes in how the prostate cells look under
the microscope, but the abnormal cells don't look like they've grown
into other parts of the prostate (like cancer cells would). PIN is
often divided into low-grade and-high grade. Many men begin to develop
low-grade PIN at an early age but do not necessarily develop prostate
cancer. The importance of low-grade PIN in relation to prostate cancer
is still unclear.
If high-grade PIN is found on a biopsy, there is about a 20%
chance that cancer may already be present somewhere else in the
prostate gland. This is why doctors often watch men with high-grade PIN
carefully and may advise a repeat prostate biopsy, especially if the
original biopsy did not take samples from all parts of the prostate.
Another finding that is sometimes reported on a prostate
biopsy is atypical small acinar proliferation (ASAP), which is
sometimes just called atypia.
In ASAP, the cells look like they might be cancerous when viewed under
the microscope, but there are too few of them to be sure. If ASAP is
found, there's about a 40% to 50% chance that cancer is also present in
the prostate, which is why many doctors recommend getting a repeat
biopsy within a few months.
Last Medical Review: 08/25/2008 Last Revised: 05/13/2009
|